Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01172665 · ClinicalTrials.gov registry record
Celiac Disease Database
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 1,090
- Enrollment target
NCT01172665: Completed study, sponsored by University of Chicago.
NCT01172665 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 1,090 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01172665 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 1,090 participants
- Enrollment target
Study Summary
The focus of this study is to create a database containing information about patients with celiac disease. This database will allow us to examine clinical and epidemiologic features of the University of Chicago Medical Center patient population. We have the largest population of patients with celiac disease in the mid-West and as such this study using information gathered from our database can greatly contribute to our current understanding of this disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,090 participants |
| Start Date | 2008-09 |
| Est. Completion | 2024-05-05 |
What the finished NCT01172665 record still lists
NCT01172665 is an observational study that tracks outcomes without assigning an intervention. Its 1,090 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01172665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01172665 about?
NCT01172665 is a clinical study titled "Celiac Disease Database". The focus of this study is to create a database containing information about patients with celiac disease. This database will allow us to examine clinical and epidemiologic features of the University of Chicago Medical Center patient population. We have the largest population of patients with celiac...
What is the current status of trial NCT01172665?
This trial is currently completed. The enrollment target is 1,090 participants. The study started on 2008-09. Estimated completion is 2024-05-05.
Who is sponsoring clinical trial NCT01172665?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07196722 · 1,092 participants · Phase 2
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- NCT06671483 · 1,088 participants · Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- NCT03754114 · 1,094 participants · NA
Brain Oxygen Optimization in Severe TBI, Phase 3
- NCT06118983 · 1,094 participants · NA
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia